Recomendaciones farmacológicas en la práctica diaria para el control metabólico de la diabetes mellitus tipo 2. Papel de las nuevas insulinas

Gaede, 2003, Mul- tifactorial intervention and cardiovascular disease in patients with type 2 dia betes, N Engl J Med, 348, 383, 10.1056/NEJMoa021778 Turner, 1998, The U.K. Prospective Diabetes Study. A review, Diabetes Care, 21, C35, 10.2337/diacare.21.3.C35 2006, Directrices mundiales para la diabetes tipo 2: recomendaciones para el tratamiento convencional, integral y míni mo, DiabetMed, 23, 579 2007, Standards of medical care in diabetes- 2007, Diabetes Care, 30, S4 Ampudia-Blasco, 2006, Algoritmo terapéutico de la diabetes mellitus tipo 2. Guías de actuación clínica de la diabetes mellitus, Endocrinol Nutr, 53, 10 Nathan, 2006, Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy, Diabetes Care, 29, 1963, 10.2337/dc06-9912 Jeffcoate, 2004, Diabetes control and complications: the role of glycated haemoglobin, 25 years on, Diabet Med, 21, 657, 10.1046/j.1464-5491.2003.01065.x Lebovitz, 1999, Insulin secretagogues: old a new, Diabetes Reviews, 7, 139 Rosenstock, 2006, Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients, Diabetes Care, 29, 554, 10.2337/diacare.29.03.06.dc05-0695 Fritsche, 2003, Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial, Ann Intern Med, 138, 952, 10.7326/0003-4819-138-12-200306170-00006 Riddle, 2003, The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients, Diabetes Care, 26, 3080, 10.2337/diacare.26.11.3080 Hermansen, 2006, A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes, Diabetes Care, 29, 1269, 10.2337/dc05-1365 Haak, 2005, Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes, Diabetes Obes Metab, 7, 56, 10.1111/j.1463-1326.2004.00373.x